Detalhe da pesquisa
1.
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Lancet Oncol
; 25(5): 668-682, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552658
2.
Disease Evolution Monitored by Serial Cerebrospinal Fluid Liquid Biopsies in Two Cases of Recurrent Medulloblastoma.
Int J Mol Sci
; 25(9)2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38732099
3.
MR multitasking-based dynamic imaging for cerebrovascular evaluation (MT-DICE): Simultaneous quantification of permeability and leakage-insensitive perfusion by dynamic T 1 / T 2 * mapping.
Magn Reson Med
; 89(1): 161-176, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36128892
4.
Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome.
Pediatr Blood Cancer
; 69(10): e29830, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686831
5.
Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.
Pediatr Blood Cancer
; 68(10): e29172, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125480
6.
Primary Primitive Neuroectodermal Tumor of the Spine With t(11;22): Report of 3 Cases and Review of Literature.
J Pediatr Hematol Oncol
; 43(7): e983-e986, 2021 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33480656
7.
A genome-wide association study on medulloblastoma.
J Neurooncol
; 147(2): 309-315, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32056145
8.
Primary diffuse leptomeningeal glioneuronal tumors of the central nervous system: Report of three cases and review of literature.
Pediatr Hematol Oncol
; 37(3): 248-258, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31951480
9.
Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.
J Neurooncol
; 145(2): 375-383, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31621042
10.
Clinical and neuropsychological outcome of pediatric non-midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience.
Pediatr Blood Cancer
; 66(12): e27983, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31502379
11.
A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.
J Neurooncol
; 140(3): 575-582, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30173409
12.
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.
J Neurooncol
; 138(1): 199-207, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29427149
13.
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.
Acta Neuropathol
; 134(5): 705-714, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28733933
14.
Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.
J Neurooncol
; 133(1): 119-128, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405869
15.
Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.
Pediatr Blood Cancer
; 63(9): 1527-34, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27145464
16.
Pediatric brain tumor cell lines.
J Cell Biochem
; 116(2): 218-24, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25211508
17.
Achieving target voriconazole concentrations more accurately in children and adolescents.
Antimicrob Agents Chemother
; 59(6): 3090-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25779580
18.
Central diabetes insipidus: A rare unreported side effect of temozolomide in pediatrics.
Pediatr Blood Cancer
; 67(12): e28516, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32573959
19.
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials.
J Clin Oncol
; 42(12): 1340-1343, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38394473
20.
Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.
Neurooncol Pract
; 11(2): 188-198, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38496907